internet.com
search INB
  search all of internet.com
PR ServicesGeneral InfoClient Press ReleasesFor the JournalistAffiliate ProgramSubmit a Press ReleaseTestimonialsAbout Us
INB Home
Press Release Editing & Writing
Distribution & Media Lists
International Services

Sign up for the
INB Newsletter
internet.com
IT
Developer
Internet News
Small Business
Personal Technology

Search internet.com
Advertise
Corporate Info
Newsletters
Tech Jobs
E-mail Offers

internet.commerce
Partner With Us














 
Internet News Bureau

FOR IMMEDIATE RELEASE

OVIDE® (malathion) Lotion, 0.5% Rebate Program

HAWTHORNE, NY - June 12, 2006 (INB) -- TaroPharma, a division of Taro Pharmaceuticals U.S.A., Inc., is pleased to announce that a rebate up to $50 for OVIDE® (malathion) Lotion, 0.5% is available on the www.ovide4headlice.com website. Finding out your child or other family member has head lice is unpleasant news. Head lice season is just around the corner, and the people that stand behind the clinically proven head lice treatment product, OVIDE®, are pleased to offer this rebate to assist you during your treatment process.

For further details about the rebate and to learn more about how to receive your rebate, please see the instructions on the rebate form, which is available at www.ovide4headlice.com.

OVIDE® Effectively Kills Head Lice and Eggs
OVIDE® is FDA-approved for head lice treatment. Studies have shown that OVIDE® kills head lice and their nits.

OVIDE® is an effective, prescription-only product for head lice treatment in children 6 years and older and adults. See the "About Head Lice" section on www.ovide4headlice.com for more information concerning lice resistance.

Ovide4headlice.com provides Head Lice and Head Lice Treatment Information
For information on symptoms of head lice, how head lice are transmitted, how to use a nit comb, house cleaning tips, and why using home remedies such as mayonnaise or olive oil is not recommended for treating head lice and lice infestation, go to www.ovide4headlice.com.

Safety Information: Minor side effects observed in trials of OVIDE® include a temporary increase in dandruff in those prone to this condition. Irritation to the skin and scalp is the most common adverse reaction.

Accidental contact with the eyes can result in mild conjunctivitis. OVIDE® is contraindicated for neonates and infants. Because this product contains alcohol, it is flammable. Keep away from heat sources (i.e., hair dryers, cigarettes) or open flame while hair is wet. Please see full prescribing information.

Ovide® and TaroPharma® are trademarks of Taro Pharmaceuticals U.S.A., Inc. and/or its affiliates.


Distributed by Internet News Bureau www.internetnewsbureau.com
23 Old Kings Highway South, Darien, CT 06820

Please read INB's statement about press release responsibilities: www.internetnewsbureau.com/disclaimer

e-mail this article to a colleague!